Clinical trials recruiting for Lung Squamous Cell Carcinoma
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Fulvestrant injection | 1 |
| JMT106 Injection | 1 |
| Sintilimab | 1 |
| TER-2013 | 1 |
| low-dose radiation therapy and stereotactic body radiation therapy | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Florida | 1 |
| Illinois | 1 |
| Massachusetts | 1 |
| Minnesota | 1 |
| Missouri | 1 |
| Nebraska | 1 |
| North Carolina | 1 |
| Ohio | 1 |
| Tennessee | 1 |
| Texas | 1 |
| Utah | 1 |
Top cities
Self-screener
Recruiting trials
- A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
- JMT106 Injection in the Treatment of Advanced Solid Tumors
- Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer
- The Role of ctDNA Testing Plus AI-based Pathology in Resectable LSCC
Related conditions
Trials recruiting for Lung Squamous Cell Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Lung Squamous Cell Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.